Alliance Global Partners Initiates Coverage On Evogene with Buy Rating, Announces Price Target of $1.85
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners analyst Ben Haynor has initiated coverage on Evogene (NASDAQ:EVGN) with a Buy rating and a price target of $1.85.
October 02, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evogene has been given a Buy rating by Alliance Global Partners with a price target of $1.85.
The Buy rating and price target set by Alliance Global Partners indicate a positive outlook for Evogene. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100